Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety.
L. Moth (London, United Kingdom), C. Fitzgerald (London, United Kingdom), P. Marino (London, United Kingdom), L. Osman (London, United Kingdom), L. Mcdonnell (London, United Kingdom), L. Hogg (London, United Kingdom), H. Shannon (London, United Kingdom)
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Moth (London, United Kingdom), C. Fitzgerald (London, United Kingdom), P. Marino (London, United Kingdom), L. Osman (London, United Kingdom), L. Mcdonnell (London, United Kingdom), L. Hogg (London, United Kingdom), H. Shannon (London, United Kingdom). Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety.. 522
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: